ccr5 genotype may confer resistance to vertical hiv-1

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update CCR5 Genotype May Confer Resistance to Vertical HIV-1
July 27, 1999

Reuters Health Information Services (07/26/99) Investigators believe that children who inherit the homozygous delta 32 CCR5 genotype may be protected from vertical HIV-1 infection. The homozygous delta 32 CCR5 genotype has been observed to confer resistance in adults. Dr. Sean Philpott, of the New York State Department of Health in Albany, and colleagues, investigated by determining the CCR5 genotype in 552 infants born to women infected with HIV-1. The researchers, who reported their findings in the July 1st issue of the Journal of Acquired Immune Deficiency Syndromes, suggest that the delta 32 homozygous genotype may provide resistance against both sexual and parental transmission of HIV-1.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 SWITZERLAND: Swiss TB Rate Below European Average SOUTH CAROLINA: DHEC Orders North Charleston Clinic to Halt Invasive Procedures CANADA: New Facility Unveiled for Homeless With Hepatitis C FLORIDA: Gospel of Health: Block Party Promotes HIV and AIDS Awareness CALIFORNIA: 2Cents Theatre Group Announces Plans to Benefit HIV/AIDS Organizations with RENT UNITED STATES: HCV Prevalence Higher Among Asian-Americans WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM MICHIGAN: Michigan Department of Community Health Encourages Testing for America's Silent Epidemic: Viral Hepatitis Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name? FLORIDA: Gospel of Health: Block Party Promotes HIV and AIDS Awareness CALIFORNIA: 2Cents Theatre Group Announces Plans to Benefit HIV/AIDS Organizations with RENT WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM The next generation of Malawi's children stay HIV free with Option B+Big jump in HIV among Navajo in New Mexico Policy change has yet to affect HIV-positive sailors UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient
Copyright © 1999 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in July 27, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.